Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Oruka Therapeutics Inc., 2 years.
Oruka Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Oruka Therapeutics Inc. June 2, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 12, 2026 | Oruka Therapeutics Inc. | Open-market sale | −12,583 | $70.11 | $882,194 |
| Jun 11, 2026 | Oruka Therapeutics Inc. | Open-market sale | −22,417 | $70.13 | $1,572,104 |
| May 21, 2026 | Oruka Therapeutics Inc. | Option exercise | +38,689 | $6.84 | $264,633 |
| May 21, 2026 | Oruka Therapeutics Inc. | Option exercise | +11,904 | $7.80 | $92,851 |
| May 21, 2026 | Oruka Therapeutics Inc. | Option exercise | +11,667 | $11.77 | $137,321 |
| May 21, 2026 | Oruka Therapeutics Inc. | Open-market sale | −38,318 | $58.43 | $2,238,921 |
| May 21, 2026 | Oruka Therapeutics Inc. | Open-market sale | −53,447 | $59.10 | $3,158,718 |
| May 21, 2026 | Oruka Therapeutics Inc. | Open-market sale | −13,235 | $59.97 | $793,703 |
| Jan 23, 2026 | Oruka Therapeutics Inc. | Other | +116,483 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.